Gut microbiota analysis for prevent COVID-19. Microviable Therapeutics

Gut microbiota analysis may help prevent the more serious effects of COVID-19. With this premise, Microviable seeks funding to design…

Read more
Gut microbiota analysis for prevent COVID-19. Microviable Therapeutics
Towards controlling the “second brain” that inhabits your intestines

Towards controlling the “second brain” that inhabits your intestines

View more at “La Voz de Asturias” Microviable Therapeutics offers the possibility of performing a microbiota transplant more comfortably and even…

Read more

Microviable Therapeutics pioneer in the field of microbiota.

El Comercio (Diario de Asturias), highlights Microviable's activity in “the long-term isolation and storage of the microbiota under viable conditions,…

Read more
Microviable Therapeutics pioneer in the field of microbiota.
Microviable Therapeutics pioneers the microbiota storage

Microviable Therapeutics pioneers the microbiota storage

During the last week, the media had covered the exclusive service of intestinal microbiota storage that we offer. Since September…

Read more

Our Research published on Scientific Reports

Microviable Therapeutics published the latest research in the prestigious journal Scientific Reports. In this scientific manuscript we showed the efficacy…

Read more
Our Research published on Scientific Reports
Seal of Excellence from the European Commission

Seal of Excellence from the European Commission

Microviable Therapeutics is awarded with the Seal of Excellence by the European Commission under the EU Framework Programme H2020 for…

Read more

Horizonte Pyme 2017

Project Concession Collection Device for keeping microbiota viability. Microviable Therapeutis is awarded with the Horizonte Pyme 2017 competitiveness funding for…

Read more
Horizonte Pyme 2017